高雄市生物科技發展協會|http://www.khba.org.tw
會員登入
記住帳號 自動登入
會員名錄
各式辦法
下載專區
留言板
您目前的位置:首頁 / 活動與新訊
Gut microbiome plays a role in immune response to mRNA COVID vaccines
活動日期:2024.01.23
2024.01.23  

Gut microbiome plays a role in immune response to mRNA COVID vaccines

https://reurl.cc/v0anlk

Jan 4 2024Karolinska Institutet

Researchers from Karolinska Institutet in Sweden have discovered that the gut microbiome can influence how well people respond to mRNA COVID vaccines. The study, published in the journal npj Biofilms and Microbiomes, suggests that certain bacteria in the gut can enhance the immune response to the vaccine, whereas other bacteria may weaken it.

The gut microbiome is the collection of microorganisms that live in our digestive tract. It plays an important role in many aspects of our health, such as digestion, metabolism, and immunity. The researchers wanted to find out if the gut microbiome also affects the response to mRNA COVID vaccines. To do this, the researchers collected stool samples from 68 people living with HIV and 75 healthy individuals before their first mRNA COVID vaccine dose.

The researchers analysed the microbiome composition using a technique called 16S rRNA sequencing, which identifies the types and relative abundance of bacteria in the samples. They also measured the levels of antibodies and immune cells that were produced after the vaccination.

We correlated the microbial composition with immune responses and patient characteristics. This comprehensive analysis included age, gender, body mass index and clinical factors for people living with HIV, aiming to understand the complex relationship between gut microbes and vaccine efficacy."

Piotr Nowak, principal investigator, senior physician and associate professor at Karolinska Institutet's Department of Medicine, Huddinge

The results showed that the initial makeup of the gut microbiome could predict the immune response to the vaccine in both groups. They found that a less diverse gut microbiome was associated with a stronger vaccine response, marked by higher levels of spike protein antibodies and spike specific CD4 T-cells. These are key components of the immune system that help to neutralize the virus and prevent severe infection.

The researchers also identified specific bacteria that were linked with better or worse vaccine responses. For example, they found that Lactobacillus, Bacteroides, and Lachnospira were associated with higher antibody and immune cell levels, while Cloacibacillus was associated with lower antibody levels. They also found that Bifidobacterium and Faecalibacterium were microbial markers of individuals with higher antibody levels.

Omics eBook Compilation of the top interviews, articles, and news in the last year.Download the latest edition

According to the researchers, the study highlights the significant role of the gut microbiome in the effectiveness of mRNA COVID vaccines. The findings could lead to developing microbiota-focused treatments to enhance vaccine responses, especially in groups that may have weaker responses, such as the elderly or immunocompromised individuals. The potential strategies could include changing the diet or taking probiotics to improve the gut microbiome and immunity, the researchers suggest.

The study was conducted in collaboration with the Karolinska University Hospital, and SciLifeLab National Genomics Infrastructure in Stockholm, Sweden. The research was funded by Region Stockholm, the Swedish Research Council, and Physicians Against AIDS.

Source:

Karolinska Institutet

Journal reference:

Ray, S., et al. (2023). Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV. npj Biofilms and Microbiomesdoi.org/10.1038/s41522-023-00461-w.

共有314筆資料 頁數: 第14頁(共16頁)
編號 標題 新增日期
1 97年品牌台灣發展計畫 2008.05.29
2 2008『重點生技廠商客製化服務及輔導計畫』遴選作業 2008.06.09
3 外貿協會「2008年中東市場商機說明會」 2008.05.28
4 「醫療電子產業推廣服務計畫」提供醫材產業免費諮詢診斷服務 2008.06.04
5 生技產業智慧財產管理實務研討會 2008.06.03
6 美國約翰霍普金斯大學---創造國際化競爭力研習會&高階公共衛.. 2008.05.26
7 基因體醫學暨生技製藥國家型科技計畫 聯合研發成果廠商說明會 2008.05.06
8 「科技化健康照護創新服務計畫」說明會 2008.04.28
9 [徵求參與廠商]經濟部工業局97年度智慧型醫療電子產業推廣與輔.. 2008.04.22
10 2008生物技術專利分析師實務認證班(2008/6/7-7/12) 2008.05.07
11 生技產業聯盟服務平台說明會 2008.04.17
12 「從國內外參展談專利侵權因應之道」說明會 2008.04.29
13 藥事論壇講座(第二十八屆) 『執行多國家/多中心臨床試驗之檢討.. 2008.04.23
14 台灣-紐西蘭 保健食品國際視訊研討會 2008.04.07
15 2008年度「SNQ國家品質標章暨國家生技醫療品質獎」報名作業正.. 2008.04.07
16 歡迎企業及相關健康照護服務機構 研提科技化健康照護科專計畫 2008.04.11
17 台灣銀髮產業展5月登場 補助邀請買主來台 2008.04.04
18 美德向邦、哈佛健康事業、萬芳醫院及巨研科技等10項計畫獲經濟.. 2008.04.01
19 經濟部推動科技化健康照護創新服務計畫 鼓勵創新服務研發期許.. 2008.03.21
20 村上和雄教授演講會:喚醒沉睡中的遺傳基因 2008.03.10
上一頁  1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16  下一頁
版權所有©2006 高雄市生物科技發展協會 所有文字、資料禁止轉用
地址:高雄市中正一路120號14樓之3 TEL:(07)591-9569 / FAX:(07)591-9018 / e-mail: khba.tw@gmail.com
累積進站人數:3123280